Literature DB >> 25024787

Opening the door to new therapeutic options with open label studies for children with detrusor overactivity.

Sumit Dave1.   

Abstract

Entities:  

Year:  2014        PMID： 25024787      PMCID： PMC4081247          DOI： 10.5489/cuaj.2180

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  3 in total

1.  Double anticholinergic therapy for refractory neurogenic and nonneurogenic detrusor overactivity in children: Long-term results of a prospective open-label study.

Authors:  Geneviève Nadeau; Annette Schröder; Katherine Moore; Lucie Genois; Pascale Lamontagne; Micheline Hamel; Eve Pellerin; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.

Authors:  Adrian Wagg; Mark Dale; Reiner Tretter; Bridget Stow; Gerhard Compion
Journal:  Eur Urol       Date:  2013-01-11       Impact factor: 20.096

3.  Reviewing definitions of urinary continence in the contemporary spina bifida literature: a call for clarity.

Authors:  Jessica C Lloyd; Unwanaobong Nseyo; Ramiro J Madden-Fuentes; Sherry S Ross; John S Wiener; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2013-03-16       Impact factor: 1.830
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.